See more : Revolution Beauty Group plc (REVB.L) Income Statement Analysis – Financial Results
Complete financial analysis of Bitmis Corp. (BIMT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bitmis Corp., a leading company in the Personal Products & Services industry within the Consumer Cyclical sector.
- Delwinds Insurance Acquisition Corp. (DWIN) Income Statement Analysis – Financial Results
- Maruwa Co., Ltd. (MAW.L) Income Statement Analysis – Financial Results
- Shandong Yabo Technology Co., Ltd (002323.SZ) Income Statement Analysis – Financial Results
- Shanghai Prisemi Electronics Co.,Ltd. (688230.SS) Income Statement Analysis – Financial Results
- Biophytis S.A. (ALBPS.PA) Income Statement Analysis – Financial Results
Bitmis Corp. (BIMT)
Industry: Personal Products & Services
Sector: Consumer Cyclical
About Bitmis Corp.
Bitmis Corp. focuses on the provision of business consulting services for entities and individuals in Thailand. It intends to offer investment portfolio formation, crediting, tax planning, and legal services, as well as obtain the certificate of the Board of Investment of Thailand. The company was founded in 2016 and is based in Bangkok, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 463.08K | 829.37K | 771.76K | 0.00 | 0.00 | 17.65K | 10.50K | 0.00 |
| Cost of Revenue | 371.46K | 598.88K | 654.85K | 0.00 | 0.00 | 5.26K | 0.00 | 0.00 |
| Gross Profit | 91.62K | 230.49K | 116.91K | 0.00 | 0.00 | 12.39K | 10.50K | 0.00 |
| Gross Profit Ratio | 19.79% | 27.79% | 15.15% | 0.00% | 0.00% | 70.21% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 30.21K | 0.00 | 0.00 | -0.61 | -0.21 | 0.00 |
| General & Administrative | 1.18M | 7.36K | 1.37M | 0.00 | 21.78K | 25.76K | 12.66K | 941.00 |
| Selling & Marketing | 20.06K | 182.90K | 14.22K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.20M | 7.36K | 1.39M | 0.00 | 21.78K | -0.61 | -0.21 | 941.00 |
| Other Expenses | 0.00 | -131.00K | 0.00 | 0.00 | -21.78K | 3.00 | -3.00 | -1.00 |
| Operating Expenses | 1.20M | 7.36K | 1.39M | 0.00 | 21.78K | 25.76K | 12.66K | 941.00 |
| Cost & Expenses | 1.58M | 7.36K | 2.05M | 0.00 | 21.78K | 28.46K | 12.66K | 941.00 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 34.66K | 73.45K | 13.81K | 206.30K | 21.78K | 28.46K | 12.66K | 941.00 |
| EBITDA | -1.08M | -460.33K | -1.26M | 0.00 | -21.78K | -5.55K | -1.79K | -941.00 |
| EBITDA Ratio | -232.75% | -0.89% | -163.38% | 0.00% | 0.00% | -46.74% | -17.03% | 0.00% |
| Operating Income | -1.11M | -7.36K | -1.27M | 0.00 | -21.78K | 2.56K | 375.00 | -941.00 |
| Operating Income Ratio | -240.23% | -0.89% | -165.17% | 0.00% | 0.00% | 14.49% | 3.57% | 0.00% |
| Total Other Income/Expenses | 16.19K | -131.00K | 270.00 | 0.00 | 0.00 | -2.70K | 0.00 | 0.00 |
| Income Before Tax | -1.10M | -7.36K | -1.27M | 0.00 | -21.78K | -8.25K | -1.78K | -941.00 |
| Income Before Tax Ratio | -236.74% | -0.89% | -165.13% | 0.00% | 0.00% | -46.74% | -16.95% | 0.00% |
| Income Tax Expense | -391.00 | -204.45K | 0.00 | 0.00 | -171.86K | -10.81K | -2.16K | -940.00 |
| Net Income | -1.10M | -7.36K | -1.27M | 0.00 | -21.78K | -10.81K | -2.16K | -941.00 |
| Net Income Ratio | -236.65% | -0.89% | -165.13% | 0.00% | 0.00% | -61.23% | -20.60% | 0.00% |
| EPS | -0.15 | 0.00 | -0.13 | 0.00 | 0.00 | 9.82M | 0.00 | 0.00 |
| EPS Diluted | -0.15 | 0.00 | -0.13 | 0.00 | 0.00 | 9.82M | 0.00 | 0.00 |
| Weighted Avg Shares Out | 7.25M | 6.25M | 10.00M | 0.00 | 6.25M | 0.00 | 6.25M | 6.25M |
| Weighted Avg Shares Out (Dil) | 7.25M | 6.25M | 10.00M | 0.00 | 6.25M | 0.00 | 6.25M | 6.25M |
Neuboron Medical Group Advances Cancer Treatment: Introducing Next-Generation Boron Neutron Capture Therapy
Source: https://incomestatements.info
Category: Stock Reports